Description
Anti-Bevacizumab Antibody (AY12) (recommended for neutralizing assay) | BEB-Y12-100ug| Gentaur Distribution US, UK & Europe
A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF) . Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.
Source: Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and BN/Alymphocytes obtained from a mouse immunized with Bevacizumab F (ab') 2.
Molecule: Bevacizumab.
Species: Mouse.
Tag: N/A.
Conjugate: Unconjugated.
Purity: 95%.
Charactirization: Tris with Glycine, Arginine and NaCl, pH7.5.
Storage Conditions: -20℃.
Shipping Conditions: RT
